Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, -interferon, cisplatin (FAP)

By Tu S.-M.   Millikan R.E.   Pagliaro L.C.   Daliani D.   Papandreou C.N.   Kim J.   Chen D.-T.   Williams D.L.   Logothetis C.J.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 342-348

Elsevier

Access to resources Recommend Favorite

Phase II trial of cisplatin, 5-fluorouracil, and interferon- -2B as first line treatment of advanced urothelial cancer

By Bazarbashi S.   Pai C.   Raja M.A.   Rahal M.   Ezzat A.   Hanash K.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 3, 2003-05 ,pp. : 185-189

Elsevier

Access to resources Recommend Favorite

A phase II study of combined chemotherapy with methotrexate, 5-fluorouracil, and low-dose cisplatin (MFP) for histologically diffuse-type advanced and recurrent gastric cancer (KDOG9501)

By Nakayama Norisuke   Koizumi Wasaburo   Tanabe Satoshi   Sasaki Tohru   Saigenji Katsunori  

Gastric Cancer, Vol. 9, Iss. 3, 2006-08 ,pp. : 185-191

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Advanced or Recurrent Endometrial Carcinoma with Combination of Etoposide, Cisplatin, and 5-Fluorouracil: A Phase II Study

By Pierga J.Y.   Dieras V.   Paraiso D.   Dorval T.   Palangie T.   Beuzeboc P.   Jouve M.   Scholl S.M.   Garcia-Giralt E.   Pouillart P.  

Gynecologic Oncology, Vol. 60, Iss. 1, 1996-01 ,pp. : 59-63

Academic Press

Access to resources Recommend Favorite

A phase I study of paclitaxel, cisplatin, and fluorouracil (TCF) for advanced gastric cancer

By Hara Takuo   Omura Kenji   Hirano Makoto   Asada Yasuyuki   Munemoto Yoshinori   Sakamoto Junichi  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 631-636

Springer Publishing Company

Access to resources Recommend Favorite